This work investigates X-PACT (X-ray Psoralen Activated Cancer Therapy): a new approach for the treatment of solid cancer. X-PACT utilizes psoralen, a potent anti-cancer therapeutic with current application to proliferative disease and extracorporeal photopheresis (ECP) of cutaneous T Cell Lymphoma. An immunogenic role for light-activated psoralen has been reported, contributing to long-term clinical responses.
X-Ray Psoralen Activated Cancer Therapy
Previous
Previous
Psoralen: A Narrative Review of Current and Future Therapeutic Uses - Journal of Cancer Research and Clinical Oncology
Next
Next